Merck KGaA – Condensate-Based Cell-Free Screening Assays for PPIs (2026)
Innovative Assays to Detect & Modulate Protein-Protein Interactions
Organization: Merck KGaA, Darmstadt, Germany
Support Type: Research grant
Award Amount: Up to €100,000 per year (up to 3 years)
Deadline: August 31, 2026
Geographic Focus: Global
About the Program
This opportunity supports development of innovative cell-free screening assays that leverage condensate-inspired systems to enhance detection of weak protein-protein interactions.
The goal is to better replicate intracellular macromolecular environments and improve screening sensitivity.
Proposal Expectations
Applicants should:
- Describe anticipated sensitivity improvements
- Outline advantages over traditional screening methods
- Identify the types of PPIs being targeted
Funding
- One grant available
- Up to €100,000 per year
- Maximum 3-year duration
Apply / Learn More
➡️ https://www.emdgroup.com/en/research/open-innovation/research-grants.html
Corporate Grants Guide Notes
Deadline: August 31, 2026
Best For: Molecular biology and drug discovery researchers
